My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AdvisorShares Psychedelics ETF (NY:PSIL)

19.28 +0.83 (+4.48%)

Streaming Delayed Price Updated: 12:11 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Psychedelics ETF

< Previous 1 2 3 4 5 Next >

An Update On The Performance Of The 7 Largest Psychedelic Stocks ↗

March 19, 2023

The 7 largest psychedelic drug stocks are ranked as to their stock performances since the beginning of March and year-to-date, their likelihood of financial distress, analyst price forecasts and the...

Via Talk Markets

The "Multi-Bagger" Portfolio: An Update ↗

March 18, 2023

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 - DOWN 73% vs. 2021 - but perhaps some of them will bounce back with major - dare I say

Via Talk Markets

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More ↗

March 13, 2023

Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial

Via Benzinga

Largest Psychedelic Stocks Down 13% Last Week; Down 20% YTD ↗

March 13, 2023

This article presents the likelihood of the 7 largest psychedelic drug experiencing Financial Distress within the next 2 years, their average year-end price targets and their stock performances last...

Via Talk Markets

Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More ↗

March 07, 2023

Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been...

Via Benzinga

An Aggressive ETF Portfolio For 2023 ↗

March 05, 2023

If you are bullish on any of the cannabis, psychedelic, cryptocurrency or gold and silver junior miner categories you might want to buy one or more of the ETFs highlighted in this article.

Via Talk Markets

Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More ↗

February 27, 2023

Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and...

Via Benzinga

"Rags-To-Riches" Portfolio Outpacing S&P 500 By 2-To-1 Margin ↗

February 27, 2023

The

Via Talk Markets

"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD ↗

February 26, 2023

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some will bounce back with

Via Talk Markets

Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD ↗

February 26, 2023

The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage...

Via Talk Markets

Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More ↗

February 21, 2023

Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and...

Via Benzinga

"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin ↗

February 19, 2023

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with

Via Talk Markets

Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More ↗

February 13, 2023

Psychedelics Legislation: The Latest On Hawaii, Virginia, Missouri & More

Via Benzinga

Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics ↗

February 06, 2023

Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically...

Via Benzinga

The 7 Most Promising Psychedelic Stocks to Buy in February ↗

February 05, 2023

These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

Via InvestorPlace

Psyched: New MO, MA & NY Bills, Oregon's Psilocybin Services, MDMA Exports, 3D Farm & More ↗

January 31, 2023

Three More State-Level Psychedelic Bills In The Works: MO, MA And NY

Via Benzinga

Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More ↗

January 25, 2023

Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First?

Via Benzinga

Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More ↗

January 17, 2023

Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.

Via Benzinga

Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More ↗

January 10, 2023

Guess Which East Coast State Is Now Discussing Legalizing Psychedelics? Decriminalizing psychedelics is one thing, but fully legalizing them is another. That's currently a measure before New York's...

Via Benzinga

Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More ↗

December 28, 2022

Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries

Via Benzinga

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More ↗

December 19, 2022

Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.

Via Benzinga

Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More ↗

December 13, 2022

Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers

Via Benzinga

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project ↗

December 06, 2022

Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and...

Via Benzinga

Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More ↗

November 29, 2022

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

Via Benzinga

Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More ↗

November 21, 2022

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

Via Benzinga

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup ↗

November 15, 2022

Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics

Via Benzinga

A Comparison Of 5 Psychedelic ETFs And Indices ↗

November 11, 2022

A look at 2 psychedelic ETFs and 3 tracking (non-trading) indices in the sector.

Via Talk Markets

Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More ↗

November 07, 2022

Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'

Via Benzinga

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More ↗

November 01, 2022

15 Global Psychedelics Executives To Keep An Eye On In 2022

Via Benzinga

Psyched: VC Fund Invests $50M In Psychedelics, Musk's 'Exploratory Journeys', Native American Use Of Peyote And More ↗

October 14, 2022

Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.